Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04086875 · ClinicalTrials.gov registry record · NA

A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer

A NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, sponsored by Thomas Jefferson University.

Active
Registry status
NA
Development phase
332
Enrollment target
7
Study locations

NCT04086875 is a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8 that is active but no longer recruiting, run by Thomas Jefferson University. The registered enrollment target is 332 participants, above the 301-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (10% higher). The trial reports 7 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04086875, a NA study of Anatomic Stage III Breast Cancer AJCC v8 and Anatomic Stage II Breast Cancer AJCC v8, is active but no longer recruiting, sponsored by Thomas Jefferson University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
332 participants
Enrollment target
7
Study locations

Study Summary

This trial studies how well a text-based intervention works in improving adherence to hormone therapy in patients with stage I-III hormone receptor positive breast cancer. Women often require long term therapy with adjuvant hormone therapy to prevent the cancer from returning and to improve overall survival. Side effects from hormone therapy may prevent some women from staying adherent to their medication therapy. A text-based intervention may provide educational information to breast cancer patients who are undergoing adjuvant hormone therapy.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Best Practice
  • BEHAVIORAL Focus Group
  • OTHER Text Message

Study Locations (7)

Pennsylvania

  • Jefferson Health - Abington - Abington
  • Doylestown Hospital - Doylestown
  • Sidney Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
  • Fox Chase Cancer Center - Philadelphia
  • Jefferson Health - Northeast (Aria Torresdale) - Philadelphia
  • Thomas Jefferson University - Methodist Hospital - Philadelphia

New Jersey

  • Jefferson Health - South Jersey - Sewell

Trial Details

FieldValue
Enrollment Target 332 participants
Start Date 2018-11-07
Est. Completion 2024-09-24
Phase NA

Sponsor

Thomas Jefferson University

292 total trials

What the Registry Record Tells You About NCT04086875

The ClinicalTrials.gov registry entry for NCT04086875 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 332 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 301-participant average among 84 other Anatomic Stage III Breast Cancer AJCC v8 trials with a reported enrollment target (10% higher). The listed sponsor is Thomas Jefferson University, which has 292 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Anatomic Stage III Breast Cancer AJCC v8 appearing as the primary indexed condition, and to 4 interventions - of which Questionnaire Administration is the first listed.

NCT04086875 reports 7 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, New Jersey.

Frequently Asked Questions

What is clinical trial NCT04086875 about?

NCT04086875 is a clinical study titled "A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer". This trial studies how well a text-based intervention works in improving adherence to hormone therapy in patients with stage I-III hormone receptor positive breast cancer. Women often require long term therapy with adjuvant hormone therapy to prevent the cancer from returning and to improve overall ...

What is the current status of trial NCT04086875?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 332 participants. The study started on 2018-11-07. Estimated completion is 2024-09-24.

What conditions does trial NCT04086875 study?

This clinical trial studies the following conditions: Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8.

What interventions are being tested in trial NCT04086875?

The interventions under investigation include: Questionnaire Administration (OTHER), Best Practice (OTHER), Focus Group (BEHAVIORAL), Text Message (OTHER).

Who is sponsoring clinical trial NCT04086875?

This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04086875 being conducted?

This trial has 7 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anatomic Stage III Breast Cancer AJCC v8

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.